Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy

BACKGROUND AND OBJECTIVES: During the COVID-19 pandemic, B cell depleting therapies pose a clinical concern for patients with neuroimmune conditions, as patients may not mount a sufficient immune response to SARS-CoV-2 infection and vaccinations. Studies to-date have reported conflicting results on...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazzi, Sam A., Maguire, Cole, Holay, Nisha, Geltman, Janelle, Hurley, Kerin, DiPasquale, Chris, Abigania, Melissa, Olson, Eric, Ehrlich, Lauren I.R., Triplett, Todd A., Melamed, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511881/
https://www.ncbi.nlm.nih.gov/pubmed/36223705
http://dx.doi.org/10.1016/j.msard.2022.104195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511881/
https://www.ncbi.nlm.nih.gov/pubmed/36223705
http://dx.doi.org/10.1016/j.msard.2022.104195

Ejemplares similares